Assay to Detect Inhibitory Substances in Serum of Patients with Acute Liver Failure

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International Journal of Artificial Organs

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/039139889902200209PMID 10212046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

  1997cited by this paper
• The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure.

  1997cited by this paper
• The 55-kD Tumor Necrosis Factor Receptor and CD95 Independently Signal Murine Hepatocyte Apoptosis and Subsequent Liver Failure

  1996cited by this paper
• Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity.

  1995cited by this paper
• Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure

  1994cited by this paper
• The effect of γ-Aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats

  1993cited by this paper
• Acute liver failure: redefining the syndromes.

  1993cited by this paper
• Interferon‐γ inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liver

  1993cited by this paper
• Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.

  1993cited by this paper
• The effect of gamma-aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats.

  1993cited by this paper
• Classification of acute liver failure

  1993cited by this paper
• Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2

  1989cited by this paper
• Early indicators of prognosis in fulminant hepatic failure.

  1989cited by this paper
• Fulminant hepatitis: Mayo Clinic experience with 34 cases.

  1985cited by this paper
• Isolation, culture, and transplantation of human hepatocytes.

  1982cited by this paper
• Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.

  1982cited by this paper
• Hepatotoxic Effects of Sera from Patients with Fulminant Hepatitis B on Isolated Rat Hepatocytes in Culture

  1981cited by this paper
• The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes.

  1976cited by this paper
• Liver regeneration and uraemia.

  1973cited by this paper

• UvA-DARE ( Digital Academic Repository ) Human liver cell lines for the AMC-bioartificial liver

  2012cites this paper
• Human liver cell lines for the AMC-bioartificial liver

  2012cites this paper
• Human liver cell lines for the AMC-bioartificial liver

  2012cites this paper
• The Effect of Rat Acute-Liver-Failure Plasma on HepaRG Cells

  2012cites this paper
• Effects of plasma from acute-on-chronic liver failure patients on immortalized human hepatocytes in vitro.

  2011cites this paper
• In Vitro Effects of Sera From Children With Acute Liver Failure on Metabolic and Synthetic Activity of Cryopreserved Human Hepatocytes

  2009cites this paper
• Future of bioartificial liver support.

  2009cites this paper
• GUIDELINES FOR CLINICAL PRACTICE Future of bioartificial liver support

  2009cites this paper
• Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy.

  2007cites this paper
• Effects of serum from patients with acute liver failure due to paracetamol overdose on human hepatocytes in vitro.

  2005cites this paper
• Dialysis techniques: hemoperfusion

  2004cites this paper
• Activin A and follistatin in acute liver failure

  2003cites this paper
• Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus)

  2003cites this paper
• Artificial liver support devices for fulminant liver failure.

  2001cites this paper